Call Us: 1.800.873.5297


What Is a Drug Recall?

drug recall is when patients and consumers are asked to stop using, destroy, or return a drug. Sometimes, the drug in question is the entire supply of a particular drug. This type of drug recall is issued when a drug is determined to be unreasonably dangerous, and the drug is being removed from the market, temporarily or permanently. Other times, only particular lots of a drug are recalled, typically because the drug is contaminated or otherwise violates quality control standards of the Food and Drug Administration (FDA) or the manufacturer. Drug recalls can be either voluntary (sometimes in response to FDA request) or initiated by the FDA.

If you have suffered an injury as a result of a dangerous drug recalled by the FDA or the manufacturer, the pharmaceutical injury litigation lawyers at Schlichter, Bogard & Denton can help you understand your legal options.  Please call or email us today for a free consultation.

Drug Recall Basics

Drug recalls are intended to remove drugs that in one way or another violate the laws administered by the FDA, or new information undermines a drug’s FDA approval. Drug recalls are intended to remove a defective drug from the market, and should not be confused with other FDA actions like market withdrawals, safety alerts, and label alterations like adding a black box warning.  Drug recalls are divided into three classes:

  • Class I Recall means that use of or exposure to the recalled drug will likely cause “serious adverse health consequences or death.”
  • Class II Recall means that the recalled drug may result in a temporary or reversible condition, or has only a small chance of causing serious adverse health consequences
  • Class III Recall means that the recalled drug is not likely to cause any adverse health consequences

In addition to these classes of recall, the FDA also uses what is known as a market withdrawal to remove products that have minor violations, often not the fault of the company. Market withdrawals are commonly used when a drug has been tampered with by someone other than the company.

Voluntary or FDA-Initiated Recalls

Recalls may be initiated by the drug manufacturer on its own initiative, at the FDA’s request, or under an explicit order by the FDA.

If a recall is initiated by the drug manufacturer, the FDA still plays an important role in the design and execution of that recall. The FDA will review and suggest changes to the manufacturer’s recall strategy, including the phrasing in its communications and press releases. The FDA will also classify the recall as Class I, II, or III. The FDA also monitors the recall. The FDA may also respond to the recall with additional action, including legal penalties, inspections, and expansion of the recall to related products.

In urgent situations, the FDA may request a recall. Typically, the FDA will only request a recall when it believes a drug poses a Class I threat, and will normally only request a recall when it has sufficient evidence to suggest additional action, including seizure of applicable lots.

The FDA can also require that a firm recall its products under certain circumstances. Mandatory recalls are not applicable to most drugs, being limited to medical devices, biologics, tissue for human transplantation, infant formula, and milk.

For more information about recalled drugs, please visit our Current Recalls page.

recalled drug may be responsible for serious, permanent injury or death. If you have suffered an injury from a defective or recalled drug, the drug litigation attorneys at Schlichter, Bogard & Denton can help you understand the legal remedies available to you.  Please contact us today for a free initial consultation.

000-017   000-080   000-089   000-104   000-105   000-106   070-461   100-101   100-105  , 100-105  , 101   101-400   102-400   1V0-601   1Y0-201   1Z0-051   1Z0-060   1Z0-061   1Z0-144   1z0-434   1Z0-803   1Z0-804   1z0-808   200-101   200-120   200-125  , 200-125  , 200-310   200-355   210-060   210-065   210-260   220-801   220-802   220-901   220-902   2V0-620   2V0-621   2V0-621D   300-070   300-075   300-101   300-115   300-135   3002   300-206   300-208   300-209   300-320   350-001   350-018   350-029   350-030   350-050   350-060   350-080   352-001   400-051   400-101   400-201   500-260   640-692   640-911   640-916   642-732   642-999   700-501   70-177   70-178   70-243   70-246   70-270   70-346   70-347   70-410   70-411   70-412   70-413   70-417   70-461   70-462   70-463   70-480   70-483   70-486   70-487   70-488   70-532   70-533   70-534   70-980   74-678   810-403   9A0-385   9L0-012   9L0-066   ADM-201   AWS-SYSOPS   C_TFIN52_66   c2010-652   c2010-657   CAP   CAS-002   CCA-500   CISM   CISSP   CRISC   EX200   EX300   HP0-S42   ICBB   ICGB   ITILFND   JK0-022   JN0-102   JN0-360   LX0-103   LX0-104   M70-101   MB2-704   MB2-707   MB5-705   MB6-703   N10-006   NS0-157   NSE4   OG0-091   OG0-093   PEGACPBA71V1   PMP   PR000041   SSCP   SY0-401   VCP550  

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.